
|Articles|September 1, 2002
Up to 40% of cancers may not present clinically
Author(s)Scott Tennant
Seattle-Despite the way it was portrayed in some of the lay media, the authors of a recent study on the "overdiagnosis" of prostate cancer insist their work should not be construed as hostile to the practice of PSA screening. In fact, says one investigator, results of the study paint an overall favorable picture of screening.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Ryan Flannigan, MD, highlights phase 2 data on ST-01 for chronic scrotal content pain
2
Active surveillance use for low-risk prostate cancer reaches 93% in VA System
3
Focal therapy for prostate cancer frequently used outside guideline-supported groups
4
Higher intake of ultra-processed food associated with increased prostate cancer risk
5








